PCSA vs WELL · $5.9M cap vs P/E 100, rev $10.84B
Processa Pharmaceuticals Inc (PCSA) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported PCSA revenue for 2023-09-30 was $0. Net income was -$2.1M. PCSA currently screens at market cap $5.9M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
PCSA currently screens at market cap $5.9M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the PCSA and WELL stock pages for the full models.
Not investment advice.